What you need to know on two underestimated hormone treatments
All about deficiencies in the anterior pituitary gland hormones, ACTH (AdrenoCorticoTrope Hormone) and MSH (Melanocyte Stimulating Hormone), and their treatment:
- The impact of these deficiencies on health and their influence on various disorders such as in the case of MSH deficiency: easy sunburn, proneness to melanoma, inflammatory disease, erectile dysfunction and female sexual dysfunction; In case of ACTH deficiency: eczema, allergies, total hair loss, arthritis, adrenal deficiency and many other diseases
- Symptoms, physical signs (with pictures of patients) and laboratory tests of these deficiencies
- Studies showing the efficacy of MSH and its synthetic derivatives in reversing sexual dysfunction in males and females, frequently greater than that of traditional phosphodiesterase type 5 inhibitors such as sildenafil
- ACTH and melanotan I or II or bremelanotide (PT141) therapies: Doses, route of administration, excess signs, side effects, safety guidelines, follow-up.
Gain insight into how to efficiently treat MSH and ACTH deficiencies with melanotan I or II or bremelanotide (PT141) and ACTH. Useful information for physicians who are more advanced in hormone therapy.
- ATCH therapy for alopecia arthritis reactivate adrenals part 1
- ATCH therapy for alopecia arthritis reactivate adrenals part 2
- ATCH therapy for alopecia arthritis reactivate adrenals part 3
- MSH therapy – anti-inflammatory, for pigmentation, grey hair M II & PT 141